XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

91 hedge funds and large institutions have $709M invested in Acceleron Pharma Inc. in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 14 closing their positions.

Holders
91
Holders Change
+12
Holders Change %
+15.19%
% of All Funds
2.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
27
Increased
40
Reduced
19
Closed
14
Calls
$3.36M
Puts
$296K
Net Calls
+$3.07M
Net Calls Change
+$3.07M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$160M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$111M
3
QF
3
QVT Financial
New York
$39.2M
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$20M
5
State Street
5
State Street
Massachusetts
$18.8M

Top Sellers

1
O
1
OrbiMed
New York
$5.84M
2
DVC
2
Deer VII & Co
New York
$5.95M
3
PVMCI
3
Polaris Venture Management Co IV
Massachusetts
$95.2M
4
ICAP
4
Independence Capital Asset Partners
Colorado
$527K
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
101
A.R.T. Advisors
New York
– -$282K -8,202 Closed
PC
102
Passport Capital
California
– -$202K -5,845 Closed
BJ
103
BlackRock Japan
Japan
– -$175K -5,082 Closed
SO
104
STRS Ohio
Ohio
– -$55K -1,600 Closed
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
– -$240 -7 Closed
1 2 3 4
5